Mark A. Winter

1.5k total citations
15 papers, 1.2k citations indexed

About

Mark A. Winter is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Mark A. Winter has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Mark A. Winter's work include Drug Transport and Resistance Mechanisms (11 papers), Cancer therapeutics and mechanisms (4 papers) and HIV/AIDS drug development and treatment (4 papers). Mark A. Winter is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Cancer therapeutics and mechanisms (4 papers) and HIV/AIDS drug development and treatment (4 papers). Mark A. Winter collaborates with scholars based in United States. Mark A. Winter's co-authors include Homer L. Pearce, William T. Beck, Robert L. Shepard, Anne H. Dantzig, Ahmad R. Safa, Nicholas J. Bach, Margaret C. Cirtain, James H. Wikel, Steven Wrighton and Kazuto Yasuda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Mark A. Winter

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Winter United States 13 694 411 317 197 192 15 1.2k
Bryan H. Norman United States 26 292 0.4× 549 1.3× 166 0.5× 667 3.4× 84 0.4× 49 1.4k
Nicola F. Smith United States 16 605 0.9× 618 1.5× 47 0.1× 82 0.4× 222 1.2× 22 1.3k
Patrick Brassil United States 18 272 0.4× 548 1.3× 89 0.3× 214 1.1× 25 0.1× 28 1.2k
Natale D’Alessandro Italy 23 362 0.5× 887 2.2× 82 0.3× 265 1.3× 36 0.2× 57 1.6k
Paul Rowland United Kingdom 17 180 0.3× 712 1.7× 49 0.2× 96 0.5× 170 0.9× 29 1.3k
Cindy Q. Xia United States 20 777 1.1× 481 1.2× 71 0.2× 52 0.3× 307 1.6× 47 1.4k
Hiroyuki Masuno Japan 19 290 0.4× 309 0.8× 246 0.8× 219 1.1× 71 0.4× 37 1.1k
Curt D. Haffner United States 16 492 0.7× 616 1.5× 126 0.4× 244 1.2× 22 0.1× 22 1.2k
Sergio C. Chai United States 23 495 0.7× 625 1.5× 231 0.7× 167 0.8× 42 0.2× 49 1.4k
Maria Karlgren Sweden 19 740 1.1× 438 1.1× 62 0.2× 31 0.2× 299 1.6× 31 1.4k

Countries citing papers authored by Mark A. Winter

Since Specialization
Citations

This map shows the geographic impact of Mark A. Winter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Winter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Winter more than expected).

Fields of papers citing papers by Mark A. Winter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Winter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Winter. The network helps show where Mark A. Winter may publish in the future.

Co-authorship network of co-authors of Mark A. Winter

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Winter. A scholar is included among the top collaborators of Mark A. Winter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Winter. Mark A. Winter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bell, Michael G., Marlene L. Cohen, Mark L. Heiman, et al.. (2006). Potent benzimidazolone based human β3-adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(21). 5691–5694. 6 indexed citations
2.
Ekins, Sean, Richard B. Kim, Brenda F. Leake, et al.. (2002). Three-Dimensional Quantitative Structure-Activity Relationships of Inhibitors of P-Glycoprotein. Molecular Pharmacology. 61(5). 964–973. 138 indexed citations
3.
Ekins, Sean, Richard B. Kim, Brenda F. Leake, et al.. (2002). Application of Three-Dimensional Quantitative Structure-Activity Relationships of P-Glycoprotein Inhibitors and Substrates. Molecular Pharmacology. 61(5). 974–981. 30 indexed citations
4.
Ekins, Sean, Richard B. Kim, Brenda F. Leake, et al.. (2002). Application of Three-Dimensional Quantitative Structure-Activity Relationships of P-Glycoprotein Inhibitors and Substrates. Molecular Pharmacology. 61(5). 974–981. 155 indexed citations
5.
Ekins, Sean, Richard B. Kim, Brenda F. Leake, et al.. (2002). Three-Dimensional Quantitative Structure-Activity Relationships of Inhibitors of P-Glycoprotein. Molecular Pharmacology. 61(5). 964–973. 16 indexed citations
6.
Norman, Bryan H., Anne H. Dantzig, Julian S. Kroin, et al.. (1999). Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146. Bioorganic & Medicinal Chemistry Letters. 9(23). 3381–3386. 23 indexed citations
7.
Shepard, Robert L., et al.. (1998). Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein. Biochemical Pharmacology. 56(6). 719–727. 49 indexed citations
8.
Starling, James J., Robert L. Shepard, Jin Cao, et al.. (1997). Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein. Advances in Enzyme Regulation. 37. 335–347. 70 indexed citations
9.
Grese, Timothy A., Alexander G. Godfrey, Charles D. Jones, et al.. (1997). Structure−Activity Relationships of Selective Estrogen Receptor Modulators:  Modifications to the 2-Arylbenzothiophene Core of Raloxifene. Journal of Medicinal Chemistry. 40(2). 146–167. 152 indexed citations
10.
Grese, Timothy A., James P. Sluka, Henry U. Bryant, et al.. (1997). Molecular determinants of tissue selectivity in estrogen receptor modulators. Proceedings of the National Academy of Sciences. 94(25). 14105–14110. 211 indexed citations
11.
12.
13.
Pearce, Homer L., Mark A. Winter, & William T. Beck. (1990). Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance. Advances in Enzyme Regulation. 30. 357–373. 68 indexed citations
14.
Pearce, Homer L., Ahmad R. Safa, Nicholas J. Bach, et al.. (1989). Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.. Proceedings of the National Academy of Sciences. 86(13). 5128–5132. 199 indexed citations
15.
Pearce, Homer L., et al.. (1988). Modulation of multiple drug resistance mdr in cem vlb 100 cells structure activity relationships in a series of 100 reserpine analogs. 29. 299. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan H. Norman Breakdown of academic impact, for papers by Nicola F. Smith Breakdown of academic impact, for papers by Patrick Brassil Breakdown of academic impact, for papers by Natale D’Alessandro Breakdown of academic impact, for papers by Paul Rowland Breakdown of academic impact, for papers by Cindy Q. Xia Breakdown of academic impact, for papers by Hiroyuki Masuno Breakdown of academic impact, for papers by Curt D. Haffner Breakdown of academic impact, for papers by Sergio C. Chai Breakdown of academic impact, for papers by Maria Karlgren
Rankless by CCL
2026